Transcatheter Interventions Online 2020 - On Demand
Published: 12 June 2020
-
Views:
20
-
Likes:
7
-
Views:
20
-
Likes:
7
-
Up Next
-
4h 11m 29sPart 1 Full Programme Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, Holger Thiele, Roxana Mehran, Didier Tchetche, Ajay J Kirtane, Lars Søndergaard, Azeem Latib, Joost Daemen, Margaret B McEntegart
-
4h 7m 18sPart 2 Full Programme Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, Holger Thiele, Roxana Mehran, Didier Tchetche, Ajay J Kirtane, Lars Søndergaard, Azeem Latib, Joost Daemen, Margaret B McEntegart
Overview
The programme aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centres of excellence globally, interspersed with presentations and debate sessions.
CME Accreditation
This three-day programme has been accredited by the European Board for Accreditation in Cardiology (EBAC) for a total of 12 CME points, equating to 12 hours of learning (4 hours per day). Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website https://www.ama-assn.org/
More from this programme
Part 1
Day 1 – Structural Heart Interventions
| 1 session | |
| Full Programme | Watch now |
Part 2
Day 2 - Complex & High Risk Indicated PCI
| 1 session | |
| Full Programme | Watch now |
Part 3
Day 3 - Updates on recent trials & future technologies
| 1 session | |
| Full Programme | Watch now |
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010.
He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals.
Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently…
Kendra J Grubb
Division of Cardiothoracic Surgery, College of Physicians and Surgeons
David Hildick-Smith
MD
David Hildick-Smith is a Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and has more than 15 years experience of Interventional Cardiology.
Holger Thiele
Professor
Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Internal Medicine/Cardiology of the Heart Center Leipzig which is affiliated with the University of Leipzig.
Roxana Mehran
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine.
Dr. Mehran is currently Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past five years, she has led the development of a globally-respected data and clinical coordination center to support large, multicenter, multinational clinical trials designed, by her team, to help clinicians improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper…
Lars Søndergaard
Lars Sondergaard currently works at the Department of Cardiology, Rigshospitalet. Lars does research in Cardiology. Their current project is 'Valvular heart disease.'
Azeem Latib
Dr Latib is Associate Professor at Department of Cardiology, Montefiore Medical Center, New York, NY, US.
He is also senior lecturer at Dipartimento Cardio-Toraco-Vascolare, Ospedale di San Raffaele Istituto di Ricovero e Cura a Carattere Scientifico.
Azeem does research in Cardiology and Medicine. Their current project is 'Bioresorbable coronay scaffolds and Vascular reparative therapy.'
Qualifications
2008:Masters in interventional cardiology
2005:Certificate in cardiology, College of physicians of South Africa
2002: Fellow of the College of College of physicians of South Africa (MM Suzman Medal)
1995: Bachelor of medicine and surgery
Joost Daemen
Interventional cardiologist
Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.